Intranasal Immunization with Recombinant Lactococcus lactis Secreting Murine Interleukin-12 Enhances Antigen-Specific Th1 Cytokine Production

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Infection and Immunity

• Publication date

  2003-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.71.4.1887-1896.2003PMID 12654805PMCID PMC152106
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence.

  2002cited by this paper
• Production of Human Papillomavirus Type 16 E7 Protein in Lactococcus lactis

  2002cited by this paper
• The Role of IL-12 in Maintaining Resistance to Leishmania major1

  2002cited by this paper
• IL‐12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis

  2002cited by this paper
• Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination.

  2002cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Induction of T helper cell type 1 response and elimination of HBeAg during treatment with IL-12 in a patient with therapy-refractory chronic hepatitis B.

  2001cited by this paper
• Systemic production of IL‐12 by naked DNA mediated gene transfer: toxicity and attenuation of transgene expression in vivo

  2001cited by this paper
• Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12

  2001cited by this paper
• Bovine Rotavirus Nonstructural Protein 4 Produced by Lactococcus lactis Is Antigenic and Immunogenic

  2001cited by this paper
• Cytokines as adjuvants for the induction of mucosal immunity.

  2001cited by this paper
• Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice.

  2001cited by this paper
• Molecular cloning of gerbil interleukin 12 and its expression as a bioactive single-chain protein.

  2001cited by this paper
• The pathogenesis of advanced cervical cancer provides the basis for an empirical therapeutic vaccine.

  2001cited by this paper
• Evaluation of cytokine toxicity induced by vaccinia virus-mediated IL-2 and IL-12 antitumour immunotherapy.

  2001cited by this paper
• Expression of a bioactive bovine interleukin-12 using baculovirus.

  2000cited by this paper
• Role of IL-12 in Staphylococcus aureus-triggered arthritis and sepsis

  2000cited by this paper
• Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

  2000cited by this paper
• Phase 1 Trial of a Single Dose of Recombinant Human Interleukin—12 in Human Immunodeficiency Virus—Infected Patients with 100–500 CD4 Cells/µL

  2000cited by this paper
• Phase 1 trial of a single dose of recombinant human interleukin-12 in human immunodeficiency virus-infected patients with 100-500 CD4 cells/microL.

  2000cited by this paper
• Use of Green Fluorescent Protein To Tag Lactic Acid Bacterium Strains under Development as Live Vaccine Vectors

  2000influential reference
• Vaccination against human cancers (review).

  2000cited by this paper
• Interleukin-12 (IL-12) Enhancement of the Cellular Immune Response against Human Immunodeficiency Virus Type 1 Env Antigen in a DNA Prime/Vaccinia Virus Boost Vaccine Regimen Is Time and Dose Dependent: Suppressive Effects of IL-12 Boost Are Mediated by Nitric Oxide

  2000cited by this paper
• Production of biologically active, heterodimeric porcine interleukin-12 using a monocistronic baculoviral expression system.

  1999cited by this paper
• IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge.

  1999cited by this paper
• Survival, Physiology, and Lysis ofLactococcus lactis in the Digestive Tract

  1999cited by this paper
• Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK).

  1999cited by this paper
• Construction of a Single-Chain Interleukin-12-Expressing Retroviral Vector and Its Application in Cytokine Gene Therapy against Experimental Coccidioidomycosis

  1999cited by this paper
• Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity.

  1999cited by this paper
• Protection of Mice against Brucellosis by Vaccination with Brucella melitensisWR201(16MΔpurEK)

  1999cited by this paper
• An Export-Specific Reporter Designed for Gram-Positive Bacteria: Application to Lactococcus lactis

  1998cited by this paper
• Mucosal Delivery of Murine Interleukin-2 (IL-2) and IL-6 by Recombinant Strains of Lactococcus lactis Coexpressing Antigen and Cytokine

  1998cited by this paper
• Identification and Characterization of the Structural and Transporter Genes for, and the Chemical and Biological Properties of, Sublancin 168, a Novel Lantibiotic Produced by Bacillus subtilis 168*

  1998influential reference
• Quorum sensing-controlled gene expression in lactic acid bacteria

  1998cited by this paper
• Correlation of T‐helper secretory differentiation and types of antigen‐presenting cells in squamous intraepithelial lesions of the uterine cervix

  1998cited by this paper
• A Nine-Residue Synthetic Propeptide Enhances Secretion Efficiency of Heterologous Proteins inLactococcus lactis

  1998cited by this paper
• Expression of human interleukin 12 (hIL-12) in insect cells.

  1998cited by this paper
• Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production.

  1997cited by this paper
• Oral vaccination of mice against tetanus with recombinant Lactococcus lactis

  1997cited by this paper
• Effects of Single-Dose Interleukin-12 Exposure on Interleukin-12–Associated Toxicity and Interferon-γ Production

  1997cited by this paper
• Interleukin‐12 acts as an adjuvant for humoral immunity through interferon‐γ‐dependent and ‐independent mechanisms

  1997cited by this paper
• Interleukin-12 regulation of host defenses against Coccidioides immitis

  1996cited by this paper
• Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin

  1996cited by this paper
• Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors.

  1996influential reference
• Characterization of anti-mouse IL-12 monoclonal antibodies and measurement of mouse IL-12 by ELISA.

  1996cited by this paper
• Inhibition of angiogenesis in vivo by interleukin 12.

  1995cited by this paper
• Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity.

  1995cited by this paper
• Mouse interleukin‐12 (IL‐12) p40 homodimer: a potent IL‐12 antagonist

  1995cited by this paper
• Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity.

  1995cited by this paper
• IL-12 Deaths: Explanation and a Puzzle

  1995cited by this paper
• Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.

  1994cited by this paper
• The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

  1994cited by this paper
• Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus.

  1993cited by this paper
• Antitumor and antimetastatic activity of interleukin 12 against murine tumors

  1993cited by this paper
• Efficient plasmid mobilization by pIP501 in Lactococcus lactis subsp. lactis

  1993cited by this paper
• Molecular characterization of interleukin 12.

  1992influential reference
• Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor.

  1991cited by this paper
• Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers

  1991cited by this paper
• Use of alkaline phosphatase fusions to study protein secretion in Bacillus subtilis

  1991influential reference
• Cloning of usp45, a gene encoding a secreted protein from Lactococcus lactis subsp. lactis MG1363.

  1990cited by this paper
• Cloning and expression in E. coli of the gene for Usp45, a highly secreted protein of Lactococcus lactis MG1363.

  1990cited by this paper
• Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

  1989cited by this paper
• Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing

  1983cited by this paper
• Molecular Characterization of Interleukin 2

  1982cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Genetically Engineered Bacteria as a Promising Therapeutic Strategy Against Cancer: A Comprehensive Review

  2025cites this paper
• The Critical Role of Lactic Acid Bacteria, Existing in Breast Milk, for the Neonatal and Maternal Health: A Review

  2025cites this paper
• Assessment of recombinant Lactobacillus vector-based expressing IFITM3 protein anti-PRV infection in mice.

  2025cites this paper
• Lactococcus lactis as an Effective Mucosal Vaccination Carrier: a Systematic Literature Review

  2025cites this paper
• Precision Antimicrobial Therapy Against Fusobacterium nucleatum Using Bioengineered Probiotics Expressing Guided Antimicrobial Peptides (gAMPs)

  2025cites this paper
• Genetically Engineered Microorganisms and Their Impact on Human Health

  2024cites this paper
• Activation of Antiviral Host Responses against Avian Influenza Virus and Remodeling of Gut Microbiota by rLAB Vector Expressing rIL-17A in Chickens.

  2024cites this paper
• Targeted therapy of oncomicrobe F. nucleatum with bioengineered probiotic expressing guided antimicrobial peptide (gAMP)

  2024cites this paper
• Antioxidant and anti-inflammatory properties of water kefir microbiota and its bioactive metabolites for health promoting bio-functional products and applications

  2024cites this paper
• Lactococcus lactis as an Interleukin Delivery System for Prophylaxis and Treatment of Inflammatory and Autoimmune Diseases

  2023cites this paper
• Oral vaccination with novel Lactococcus lactis mucosal live vector-secreting Brucella lumazine synthase (BLS) protein induces humoral and cellular immune protection against Brucella abortus

  2023cites this paper
• Application and Research Progress of Recombinant Lactic Acid Bacteria by Genetic Engineering

  2023cites this paper
• Brucella abortus antigen omp25 vaccines: Development and targeting based on Lactococcus lactis

  2023influential citation
• Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health

  2022cites this paper
• Current status, and the developments of hosts and expression systems for the production of recombinant human cytokines.

  2022cites this paper
• Biotechnological Innovations and Therapeutic Application of Pediococcus and Lactic Acid Bacteria: The Next-Generation Microorganism

  2022cites this paper
• Oral vaccine against IPNV based on antibiotic-free resistance recombinant Lactobacillus casei expressing CK6-VP2 fusion protein

  2021cites this paper
• Lactococcus lactis Expressing Type I Interferon From Atlantic Salmon Enhances the Innate Antiviral Immune Response In Vivo and In Vitro

  2021cites this paper
• Pre-treatment with chicken IL-17A secreted by bioengineered LAB vector protects chicken embryo fibroblasts against Influenza Type A Virus (IAV) infection.

  2021cites this paper
• Genetic tools for the development of recombinant lactic acid bacteria

  2021cites this paper
• Neuroprotective effects of p62(SQSTM1)-engineered lactic acid bacteria in Alzheimer’s disease: a pre-clinical study

  2020cites this paper
• Lactococcus lactis NZ9000 Prevents Asthmatic Airway Inflammation and Remodelling in Rats through the Improvement of Intestinal Barrier Function and Systemic TGF-β Production

  2020cites this paper
• Microbial therapeutics for acute colitis based on genetically modified Lactococcus lactis hypersecreting IL-1Ra in mice

  2020cites this paper
• Genetics of Lactococci

  2019cites this paper
• Recombinant Lactobacillus casei Expressing Capsid Protein VP60 can Serve as Vaccine Against Rabbit Hemorrhagic Disease Virus in Rabbits

  2019cites this paper
• Immune Response to Mucosal Brucella Infection

  2019cites this paper
• Title : Designer Bacteria as Intratumoural Enzyme Biofactories

  2018cites this paper
• Generation of epidermal growth factor and green fluorescent protein coexpressing Lactobacillus acidophilus and its effect on intestinal histology improvement in mature LPS-challenged mice

  2018cites this paper
• Mucosal and systemic immune responses elicited by recombinant Lactococcus lactis expressing a fusion protein composed of pertussis toxin and filamentous hemagglutinin from Bordetella pertussis

  2018cites this paper
• Application of Lactic Acid Bacteria for Food Biotechnology

  2018cites this paper
• Genetic Engineering of Lactococcus lactis Co-producing Antigen and the Mucosal Adjuvant 3′ 5′- cyclic di Adenosine Monophosphate (c-di-AMP) as a Design Strategy to Develop a Mucosal Vaccine Prototype

  2018cites this paper
• Analysis of Immune Responses in Mice Orally Immunized with Recombinant pMG36e-SP-TSOL18/Lactococcus lactis and pMG36e-TSOL18/Lactococcus lactis Vaccines of Taenia solium

  2018cites this paper
• A review on Lactococcus lactis: from food to factory

  2017influential citation
• Recombinant Invasive Lactococcus lactis Carrying a DNA Vaccine Coding the Ag85A Antigen Increases INF-γ, IL-6, and TNF-α Cytokines after Intranasal Immunization

  2017cites this paper
• Designer bacteria as intratumoural enzyme biofactories

  2017cites this paper
• Identification and Characterization of SdbA, a Novel Thiol-Disulfide Oxidoreductase in Streptococcus gordonii

  2017cites this paper
• Construct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine

  2017cites this paper
• Expression of fibronectin binding protein A (FnBPA) from Staphylococcus aureus at the cell surface of Lactococcus lactis improves its immunomodulatory properties when used as protein delivery vector.

  2016cites this paper
• The expression of heterologous MAM-7 in Lactobacillus rhamnosus reduces its intrinsic capacity to inhibit colonization of pathogen Vibrio parahaemolyticus in vitro

  2016cites this paper
• A new lactobacilli in vivo expression system for the production and delivery of heterologous proteins at mucosal surfaces.

  2016cites this paper
• Display of recombinant proteins at the surface of lactic acid bacteria: strategies and applications

  2016cites this paper
• CXCR4(+)-targeted protein nanoparticles produced in the food-grade bacterium Lactococcus lactis.

  2016cites this paper
• Bakterie kwasu mlekowego (LAB) jako wektory do konstrukcji szczepionek

  2015influential citation
• Construction of human granulocyte-macrophage colonystimulating factor expression system using Lactococcus lactis MG1363

  2015cites this paper
• Characterization of two Lactococcus lactis zinc membrane proteins, Llmg_0524 and Llmg_0526, and role of Llmg_0524 in cell wall integrity

  2015cites this paper
• Genetically Engineered Lactococcus lactis Protect against House Dust Mite Allergy in a BALB/c Mouse Model

  2014cites this paper
• Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation

  2014cites this paper
• Recombinant Lactococcus lactis can make the difference in antigen-specific immune tolerance induction, the Type 1 Diabetes case

  2014cites this paper
• Effect of cell-surface components and metabolites of lactic acid bacteria and probiotic organisms on cytokine production and induction of CD25 expression in human peripheral mononuclear cells.

  2014influential citation
• Correlation between fibronectin binding protein A expression level at the surface of recombinant lactococcus lactis and plasmid transfer in vitro and in vivo

  2014cites this paper
• Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease

  2013cites this paper
• Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update.

  2013influential citation
• Expression of a hepatitis A virus antigen in Lactococcus lactis and Escherichia coli and evaluation of its immunogenicity

  2013cites this paper
• Development of a Stress-Inducible Controlled Expression (SICE) system in Lactococcus lactis for the production and delivery of therapeutic molecules at mucosal surfaces.

  2013cites this paper
• IL-1Ra and its Delivery Strategies: Inserting the Association in Perspective

  2013cites this paper
• Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity.

  2012cites this paper
• Immunization against Leishmania major Infection Using LACK- and IL-12-Expressing Lactococcus lactis Induces Delay in Footpad Swelling

  2012influential citation
• Review: Lactococcus Lactis: An efficient Gram positive cell factory for the production and secretion of recombinant protein

  2012cites this paper
• Inactivation of the ybdD Gene in Lactococcus lactis Increases the Amounts of Exported Proteins

  2012cites this paper
• Science against microbial pathogens : communicating current research and technological advances

  2012cites this paper
• Heterologous protein expression by Lactococcus lactis.

  2012cites this paper
• Lactococcus lactis-based vaccines from laboratory bench to human use: an overview.

  2012cites this paper
• Current status and future perspectives

  2011cites this paper
• Interaction of Probiotics with the Acquired Immune System in the Gut

  2011cites this paper
• Lactococcus lactis-based vaccines: Current status and future perspectives

  2011cites this paper
• Probiotic Bacteria and Enteric Infections

  2011cites this paper
• Production of eukaryotic antimicrobial peptides by bacteria - A review.

  2011cites this paper
• Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines

  2011cites this paper
• Secretion of Heterologous Proteins, Gram-Positive Bacteria, Lactococcus lactis

  2010cites this paper
• Analyse des effets de souches probiotiques anti-inflammatoires

  2010cites this paper
• Perspectives for the development of human papillomavirus vaccines and immunotherapy

  2010cites this paper
• Production and purification of staphylococcal nuclease in Lactococcus lactis using a new expression-secretion system and a pH-regulated mini-reactor

  2010influential citation
• Lactococcus lactis as an adjuvant and delivery vehicle of antigens against pneumococcal respiratory infections

  2010cites this paper
• Lactococcus lactis as a cell factory for delivery of therapeutic proteins.

  2010cites this paper
• Synergistic BM-DC activation and immune induction by the oral vaccine vector Streptococcus gordonii and exogenous tumor necrosis factor.

  2009cites this paper
• Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins

  2009cites this paper
• Use of lactobacilli and their pheromone-based regulatory mechanism in gene expression and drug delivery.

  2009cites this paper
• Progress in the Development of Lactococcus lactis as a Mucosal Vaccine Delivery Vehicle

  2009influential citation
• Construction of an expression vector for Lactococcus lactis based on an indigenous cryptic plasmid

  2009cites this paper
• Oral immunization of mice with recombinant Lactococcus lactis expressing porcine transmissible gastroenteritis virus spike glycoprotein

  2009cites this paper
• Utilisation des bactéries lactiques comme vecteurs vaccinaux

  2009cites this paper
• Modulation of Gut-Associated Lymphoid Tissue Functions with Genetically Modified Lactococcus lactis

  2009cites this paper
• Enhanced Secretion of Biologically Active Murine Interleukin-12 by Lactococcus lactis

  2009cites this paper
• Development of Mucosal Vaccines Based on Lactic Acid Bacteria

  2009cites this paper
• Production of biological active murine IFN-gamma by recombinant Lactococcus lactis.

  2008cites this paper
• Production of biologically active CXC chemokines by Lactococcus lactis: evaluation of its potential as a novel mucosal vaccine adjuvant.

  2008cites this paper
• Secretion of human interferon-β 1b by recombinant Lactococcus lactis

  2008cites this paper
• Expression of bioactive porcine interferon-gamma by recombinant Lactococcus lactis.

  2008cites this paper
• Enhanced Secretion of Biologically Active Murine Interleukin-12 by Lactococcus lactis

  2008cites this paper
• Expression of Bioactive Single-Chain Murine IL-12 in Transgenic Plants

  2008cites this paper
• Nasal administration of Lactococcus lactis improves local and systemic immune responses against Streptococcus pneumoniae

  2008cites this paper
• Expression of the capsid protein of porcine circovirus type 2 in Lactococcus lactis for oral vaccination.

  2008cites this paper
• Innate inflammatory responses to the Gram-positive bacterium Lactococcus lactis.

  2008cites this paper
• Intranasal vaccines for protection against resipratory and systemic bacterial infections

  2007cites this paper
• Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria.

  2007cites this paper
• Lactococcus lactis, an Efficient Cell Factory for Recombinant Protein Production and Secretion

  2007influential citation
• Intranasal Coadministration of Live Lactococci Producing Interleukin-12 and a Major Cow's Milk Allergen Inhibits Allergic Reaction in Mice

  2007cites this paper
• Effects of Intranasal Administration of a Leptin-Secreting Lactococcus lactis Recombinant on Food Intake, Body Weight, and Immune Response of Mice

  2007cites this paper
• Current Prophylactic and Therapeutic Uses of a Recombinant Lactococcus lactis Strain Secreting Biologically Active Interleukin-12

  2007influential citation
• Des bactéries pour prévenir et traiter le cancer du col de l’utérus induit par le papillomavirus humain de type 16

  2006cites this paper